Immunotherapy demonstrates significant improvement in disease free survival if used in the adjuvant setting after surgery for Non-Small Cell Lung Cancer
Trial results show that Pembrolizumab significantly improves disease-free survival.
Royal Marsden researchers have been supporting NHS England’s Targeted Lung Health Check programme which is piloting lung health checks in areas of high lung cancer incidence, including Hillingdon and Sutton.
AI study “exciting first step” towards improving post-treatment surveillance of lung cancer patients
Artificial intelligence (AI) could help guide the post-treatment surveillance of non-small cell lung cancer (NSCLC) patients and improve outcomes as a result.
Findings from a recent European study have demonstrated the positive impact of screening on stage of lung cancer diagnosis and deaths from the disease.